Repligen Corporation announced that it will release its second quarter financial results for 2025 on July 29, 2025, with a press release scheduled before the market opens and a conference call at 8:30 ...

Ladies and gentlemen, thank you for standing by. My name is [ Jereko ] and I'll be your conference operator today. At this time, I would like to welcome everyone to the Repligen Fourth Quarter 2025 ...

WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2025 financial results on Tuesday, July 29, 2025.

WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains ...

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of ...

Prosper Stars & Stripes, a long/short equity fund, recently released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net ...

Thank you, operator, and welcome to our second quarter of 2025 report. On this call, we will cover business highlights and financial performance for the 3-month period ending June 30, 2025, and we'll ...

Earnings call Repligen delivered Q4 2025 revenue of $198M (14% organic growth) and FY25 revenue of $738M (16% YoY growth), exceeding the high end of guidance. Management guided 2026 revenue of ...